Subscribe to our news feed
A question?
22/04/2024
Getinge Interim Report January-March 2024: Higher sales, strong cash flow and new products creating more customer value
“Net sales increased by 5.2% in the first quarter, of which organic net sales was unchanged despite challenging comparative figures,” says Mattias Perjos, President & CEO at Getinge. “We have a strong free cash flow and a solid financial position that enables investments in profitable growth.”
18/04/2024
NAVA – a gamechanger for neonatal care in Slovakia
When using Getinge’s patented Neurally Adjusted Ventilatory Assist (NAVA) with diaphragm monitoring (Edi) for the first time in 2021, it soon became clear to the neonatal team in the F.D. Roosevelt University Hospital in Banska Bystrica, Slovakia, that the solution would become a gamechanger for their treatment of premature babies.
11/04/2024
Getinge receives EU MDR approval of Advanta V12 covered stent system with use for patients with renal artery stenosis and/or aortoiliac occlusive disease
Getinge announces the EU MDR certification of its Advanta V12 covered stent system, highlighting its use for patients with aortoiliac occlusive disease, including lesions at the aortic bifurcation. This approval affirms the system's compliance with European Union medical device regulations and aligns its application, reflecting Getinge's commitment to quality and patient safety.
Press Contacts
Lars Mattsson
Interim EVP Brand & Communication
Phone: +46 10 335 0043
Caroline Örmgård
Head of Public & Media Relations
Phone: +46 10 335 0041
Contact us online
Click below to fill in the appropriate form. We will be in touch shortly.
Are you looking for
Image Gallery
Diverse picture format made available for press article purpose
About us
All you need to know about Getinge a one glance
Urgent Medical Device Correction
Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)
Don't miss anything
Click on the icons and follow us!